Drug intelligence / Profile preview

hydrotalcite

Development stage
Phase 4
Lead developer
Mysun Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Hydrotalcite is an antacid used to treat heartburn, dyspepsia (indigestion), gastroesophageal reflux disease, gastritis, and peptic ulcers. It is a layered double hydroxide compound composed of aluminum and magnesium that neutralizes gastric acid upon contact in the stomach[1][2][3][5]. Its mechanism of action involves direct acid neutralization as well as promoting gastric mucosal protection and healing by increasing prostaglandin E2 (PGE2) levels, activating epidermal growth factor (EGF), and counteracting cyclooxygenase (COX) inhibition caused by NSAIDs[6]. Hydrotalcite is approved for use in several countries for the relief of symptoms associated with excess gastric acidity.

Brand names
MegalacDING'AN
Other names
aluminium magnesium hydroxide carbonate hydratealuminium dimagnesium carbonate hexahydroxide tetrahydratemagnesium aluminium hydroxide carbonate hydratehydratisiertes aluminium-magnesium-hydroxycarbonat
02

Targets

mPGES-2 (Microsomal prostaglandin E synthase-2)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)EGFR (Epidermal growth factor receptor)

Beyond the preview

Go deeper on hydrotalcite.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrotalcite.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call